On November 4, 2021 Knight Therapeutics Inc. (TSX: GUD) ("Knight"), a leading pan-American (ex-USA) specialty pharmaceutical company, reported that it will release its third quarter 2021 financial results on Thursday, November 11, 2021 prior to market opening (Press release, Knight Therapeutics, NOV 4, 2021, View Source;Third-Quarter-2021-Results-Conference-Call-11-4-2021 [SID1234594488]). Following the release, Knight will hold a conference call and audio webcast. Knight cordially invites all interested parties to participate in this call.
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Date: Thursday, November 11, 2021
Time: 8:30 a.m. ET
Telephone: Toll Free: 866-269-4264 or International 1-647-792-1240
Webcast: www.gud-knight.com or Webcast
This is a listen-only audio webcast. Media Player is required to listen to the broadcast.
Replay: An archived replay will be available for 30 days at www.gud-knight.com.